Purchase of Kapa Baits for metagenomic sequencing

The Food and Drug Administration is forecasting the purchase of Kapa baits to support metagenomic screening efforts aimed at identifying insect-based filth in food products and advancing novel genomic methods for field-based detection of contaminants in food and facility environments. This acquisition is intended to enhance the agency's capability to rapidly and accurately detect biological contaminants using next-generation sequencing technologies, improving food safety surveillance and response capabilities. The procurement is linked to NAICS code 334516, indicating alignment with laboratory and diagnostic reagent manufacturing activities, and reflects a focus on innovative, science-driven solutions for public health protection. All contract-related communications and inquiries should be directed to the designated Program Point of Contact, Hfp Acquisition Liaison, at hfpacquisitions@fda.hhs.gov, while the Contracting Officer position remains to be determined. The forecast was posted on May 25, 2026, and is intended to provide industry advance notice of an upcoming procurement opportunity, though no solicitation number or specific funding amount has been disclosed. The place of performance and set-aside details are not specified, and the purchase will support the FDA’s broader mission of ensuring the safety and integrity of the nation’s food supply through cutting-edge scientific methods.